- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Celsion Corp+ Add to Watchlist
CLSN:US2.6299 USD 0.1701 6.07%
As of 20:10:00 ET on 05/22/2015.
Company Profile for Celsion Corp (CLSN)
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Key Executives for Celsion Corp (CLSN)
|Michael H TardugnoChairman/President/CEO||Khursheed AnwerExec VP/Chief Scientific Ofcr|
|Jeffrey W Church "Jeff"Senior VP/CFO/Secretary||Nicholas BorysSenior VP/Chief Medical Ofcr|